December 2025’s Promising Penny Stocks To Consider

Simply Wall St

Wed, December 3, 2025 at 1:05 PM EST 4 min read

As the U.S. markets show resilience with major indexes rising despite mixed economic signals, investors are increasingly looking beyond traditional stocks to explore other opportunities. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those seeking potential value in less conventional investments. While the term may seem outdated, these stocks can still offer significant opportunities when backed by robust financials and a clear growth path.

Click here to see the full list of 352 stocks from our US Penny Stocks screener.

We’re going to check out a few of the best picks from our screener tool.

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Pulmonx Corporation is a commercial-stage medical technology company offering minimally invasive treatments for severe emphysema, with a market cap of $72.18 million.

Operations: The company’s revenue is generated entirely from its medical products segment, totaling $91.66 million.

Market Cap: $72.18M

Pulmonx Corporation, a commercial-stage medical technology company, faces challenges as it remains unprofitable with increasing losses over the past five years. Despite this, its revenue is growing steadily, with a forecasted growth rate of 22.3% annually. The company recently reported third-quarter sales of US$21.5 million and expects full-year revenue between US$89 million and US$90 million, maintaining a gross margin of approximately 73%. Pulmonx’s financial stability is supported by sufficient cash runway for over two years. Recent executive changes include Glendon E. French’s return as CEO and Derrick Sung’s appointment as CFO amidst ongoing strategic adjustments.

• Click to explore a detailed breakdown of our findings in Pulmonx’s financial health report.

• Review our growth performance report to gain insights into Pulmonx’s future.

Simply Wall St Financial Health Rating: ★★★★★★

Overview: FutureFuel Corp. manufactures and sells diversified chemical, bio-based fuel, and bio-based specialty chemical products in the United States, with a market cap of $146.74 million.